查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1944904

無結組織縫合器材市場：依產品類型、可吸收性、給藥方式、聚合物結構、應用和最終用戶分類，全球預測，2026-2032年

Knotless Tissue-Closure Device Market by Product Type, Absorbability, Mode Of Delivery, Polymer Structure, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年無結組織閉合裝置市值為 3.6612 億美元，預計到 2026 年將成長至 3.9862 億美元，預計到 2032 年將達到 5.9584 億美元，複合年成長率為 7.20%。

關鍵市場統計數據
基準年 2025 3.6612億美元
預計年份：2026年 3.9862億美元
預測年份 2032 5.9584億美元
複合年成長率 (%) 7.20%

無結組織縫合裝置概述：檢驗臨床效用、手術效率、推廣促進因素、法規環境及其對當代外科實踐的影響

無結組織閉合裝置旨在透過材料科學、手術效率和手術系統整合，簡化縫合、縮短手術時間並提高傷口完整性。這些裝置結合了工程聚合物結構和可控輸送機制，無需手動打結即可實現牢固的組織閉合，從而取代或補充傳統打結方法。這為臨床醫生提供了穩定的張力控制，可能減少結節部位的異物感，並降低與結節斷裂和擠出相關的併發症發生率。

臨床創新、手術自動化和微創手術的發展趨勢如何重新定義設備需求並重塑各專科的手術標準

無結組織縫合器材領域正經歷變革性的轉變，這主要得益於外科技術、器材工程和醫療保健系統優先事項的整合。聚合物化學的創新催生了具有可預測拉伸強度衰減曲線的可吸收材料。這些材料與編織和單絲等先進的聚合物結構相結合，為臨床醫生提供了不同組織類型和癒合時間的客製化選擇。同時，微創手術和機器人輔助平台的持續進步，要求器械的輸送機制能夠與有限的網路基地台和可彎曲的手術器械無縫銜接，從而加速了對單切口和多孔縫合器械的需求。

評估2025年美國關稅對供應鏈、零件採購、監管完整性和全球籌資策略的連鎖影響

美國將於2025年實施的關稅政策，為依賴國際供應鏈取得關鍵醫療設備組件和成品的製造商、經銷商和醫療保健系統帶來了新的複雜性。關稅造成的成本壓力迫使企業重新評估其籌資策略，優先考慮本地供應商並實現採購管道多元化，以降低其受關稅波動的影響。因此，各機構正在權衡關稅帶來的即時成本影響與長期資本投資之間的關係，例如轉移關鍵生產流程、尋找合格的替代材料以及重新設計包裝和物流，以最大限度地降低課稅進口閾值。

針對特定細分市場的情報，揭示應用、最終用戶、吸收、給藥途徑和聚合物結構等方面的動態變化，從而指導產品開發和定位。

透過對無結組織縫合材料市場進行應用、終端用戶、吸收性、給藥方式和聚合物結構等方面的分析，可以發現針對臨床需求和醫療環境量身定做的差異化創新機會和商業化路徑。在心血管外科、一般外科、婦科、眼科、整形外科和整形外科等應用領域中，每種應用都有獨特的機械性能和操作要求。心血管外科手術需要高拉伸可靠性和可預測的長期性能，以用於瓣膜修復和血管吻合。同時，一般外科手術，例如腹壁縫合、胃腸道吻合和疝氣修補，優先考慮的是可操作性，以便快速進行腹腔內操作。婦科手術，包括剖腹產、子宮懸吊術和陰道修補術，需要使用能夠最大限度減少組織摩擦並降低敏感解剖區域刺激的材料和給藥方式。眼科應用，例如白內障手術和角膜縫合，則需要超薄的縫合線和最小的組織反應。整形外科應用，包括關節鏡。另一方面，整形外科應用，如美容和重組手術，則需要在美觀效果和最大限度減少疤痕之間取得平衡。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和需求動態將驅動產品的採用、報銷和分銷策略。

區域趨勢將在美洲、歐洲、中東和非洲以及亞太地區無結組織縫合器械的普及曲線、支付方預期和分銷模式的形成中發揮關鍵作用。在美洲，整合的醫院系統和以價值為導向的採購模式正在推動對能夠實現穩定臨床療效和精簡供應物流的器械的需求。主要都會區中的早期採用中心往往能夠促進區域醫療機構的更廣泛採用，而獎勵效率的報銷環境則加速了臨床醫生對該器械的接受度。

成熟製造商、新興創新者、契約製造製造商和臨床合作夥伴之間的競爭與合作模式正在影響市場進入策略。

無結組織縫合器材的競爭格局呈現出成熟外科器材製造商、專業創新企業、契約製造和臨床夥伴關係之間錯綜複雜的互動關係。成熟的器械製造商通常利用其廣泛的銷售管道、與外科醫生的現有關係以及豐富的監管經驗來加速產品推廣，而規模小規模、技術驅動型的公司則往往透過利基材料科學的進步或創新的給藥機制來脫穎而出。對於缺乏垂直整合製造能力的新興企業而言，契約製造製造商和工程服務供應商在快速原型製作、規模化生產和品質系統實施方面發揮著至關重要的作用。

為行業領導者提供切實可行的建議，以加速產品應用、降低商業化風險並最佳化生產和臨床證據策略。

致力於加速無結組織縫合器材推廣應用並降低其商業化風險的產業領導者，應採取一系列協調一致的措施，涵蓋臨床數據、生產策略和商業性執行。首先，應優先產生以可重複性終點為重點的、對外科醫生和採購團隊有意義的比較性臨床證據（例如，生理負荷下的縫合完整性、再次手術率和手術效率指標）。在商業推廣初期就納入前瞻性、真實世界證據的收集，可以加快證據生成速度，並有助於將其納入採購討論。

為了確保分析的嚴謹性，我們採用透明的調查方法，結合了臨床訪談、設備工程評估和二手文獻綜合。

為確保分析的嚴謹性和實際應用價值，本分析採用混合研究方法，結合了質性訪談、器材工程評估和系統性的文獻綜述。主要研究包括對循環系統、一般外科、婦科、眼科、整形外科和整形外科的臨床醫生進行結構化訪談，以及與供應鏈負責人、監管專家和器械工程師進行對話，以了解現場操作的限制和技術重點。這些訪談有助於提出假設，突出關鍵應用案例的差異，並檢驗無結縫合技術的實際性能預期。

本文回顧了相關人員在不斷發展的無結紮組織閉合裝置領域中面臨的策略意義和未來前景。

無結紮組織閉合裝置的發展軌跡正受到聚合物科學技術的進步、外科手術技術的不斷發展以及採購預期變化的影響，後者更加重視可驗證的臨床價值和價值鏈的穩健性。希望掌握這些趨勢的相關人員需要以整體觀點看待產品開發和商業化，將臨床證據、生產柔軟性和針對性培訓路徑整合起來。成功的參與企業是那些能夠根據特定手術需求（例如高次數的整形外科修復、精細的眼部閉合或高通量普通外科手術應用）客製化裝置性能，同時確保與現有器械和臨床工作流程兼容的參與者。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 無結組織縫合器材市場（依產品類型分類）

  • 無結倒刺縫合線
    • 單絲
    • 編織
  • 無結縫合錨
    • 軟組織錨定
    • 骨錨
  • 無結閉合系統
    • 皮膚閉合系統
    • 筋膜閉合系統
    • 血管閉合系統
  • 無結網狀緊固裝置
  • 輔助張緊和固定附件

第9章 依吸收率分類的無結組織縫合器材市場

  • 吸收性
    • Poliglecaprone
    • 氧環己酮聚合體
    • Polyglactin
    • 聚乙醇酸
  • 不可吸收
    • 尼龍
    • 聚酯纖維
    • 聚丙烯

10. 依給藥途徑分類的無結組織閉合裝置市場

  • 腹腔鏡
    • 多埠
    • 單切口
  • 開放性手術
  • 機器人輔助

11. 依聚合物結構分類的無結組織縫合器材市場

  • 編織
    • 塗層
    • 未塗層
  • 單絲
    • 塗層
    • 未塗層

第12章 無結組織閉合裝置市場（依應用分類）

  • 心血管系統
    • 閥門維修
    • 血管吻合術
  • 一般外科
    • 腹壁閉合
    • 胃腸吻合術
    • 疝氣修補術
  • 婦科
    • 剖腹產
    • 子宮固定術
    • 陰道修復
  • 眼科
    • 白內障手術
    • 角膜縫合
  • 整形外科
    • 關節鏡縫合
    • 韌帶修復
    • 肌腱修復
  • 整形外科
    • 整形手術
    • 重組手術

第13章 無結組織縫合器材市場（依最終用戶分類）

  • 門診手術中心
    • 醫院附屬機構
    • 獨立的
  • 診所
    • 醫院附設診所
    • 獨立診所
  • 醫院
    • 政府
    • 私人的
  • 專業中心
    • 眼科專科中心
    • 整形外科專科中心

第14章 無結組織縫合器材市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 無結組織閉合器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國無結組織縫合器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國無結組織縫合器材市場

第18章：中國無結組織縫合器材市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Angelantoni Life Science Srl
  • Angiotech Pharmaceuticals, Inc.
  • Arctiko A/S
  • Aucma Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Blue Star Limited
  • ConMed Corporation
  • Dometic Group AB
  • Evermed SRL
  • Felix Storch, Inc.
  • Fiocchetti Srl
  • Godrej & Boyce Manufacturing Co. Ltd.
  • Johnson & Johnson
  • Labcold Ltd.
  • LEC Medical
  • Medtronic plc
  • Migali Scientific
  • Smith & Nephew plc
  • So-Low Environmental Equipment Co., Inc.
  • Standex International Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • Vestfrost
  • Zhongke Meiling Cryogenics Company Limited
Product Code: MRR-F847BD9C749D

The Knotless Tissue-Closure Device Market was valued at USD 366.12 million in 2025 and is projected to grow to USD 398.62 million in 2026, with a CAGR of 7.20%, reaching USD 595.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 366.12 million
Estimated Year [2026] USD 398.62 million
Forecast Year [2032] USD 595.84 million
CAGR (%) 7.20%

A concise orientation to knotless tissue-closure devices, examining clinical utility, procedural efficiency, adoption drivers, regulatory context, and implications for surgical practice today

Knotless tissue-closure devices represent a convergence of materials science, procedural ergonomics, and surgical system integration designed to simplify suturing, reduce operative time, and improve wound integrity. These devices replace or augment traditional knotted sutures by combining engineered polymer structures and controlled delivery mechanisms to create secure tissue apposition without manual knot tying. As a result, clinicians gain consistent tension control, reduced foreign-body bulk at knot sites, and the potential to lower complication rates associated with knot failure or prominence.

Clinically, the advantages extend across specialties where precise tissue approximation is essential, and where operating room efficiency or minimally invasive access constrains manual knotting. From an innovation standpoint, the device category has matured from simple knotless anchors to integrated systems that integrate absorbability profiles, polymer geometries, and delivery modalities aligned with laparoscopic and robotic workflows. Consequently, purchasers and clinical leaders are increasingly evaluating these devices not only on immediate procedural outcomes but on downstream effects such as ease of training, inventory rationalization, and the ability to standardize suturing technique across varied user skill levels.

Transitioning from descriptive characteristics to practical implications, stakeholders should consider how knotless technologies fit within broader clinical pathways. Adoption decisions hinge on demonstrated reproducibility in closure strength, compatibility with existing instrumentation, and robust clinician education programs. Furthermore, regulatory clearance patterns and reimbursement narratives influence procurement timelines, making early engagement with clinical champions and supply chain teams essential for smooth introduction into high-volume procedural areas.

How clinical innovation, surgical automation, and minimally invasive trends are realigning device requirements and reshaping procedural standards across specialties

The landscape for knotless tissue-closure devices is undergoing transformative shifts driven by convergence across surgical technique, device engineering, and health system priorities. Innovations in polymer chemistry have enabled absorbable materials that deliver predictable tensile decay profiles, which, when paired with refined polymer structures such as braided or monofilament designs, provide clinicians with choices tailored to tissue type and healing timelines. At the same time, the relentless advance of minimally invasive surgery and robotic-assisted platforms demands delivery mechanisms that integrate seamlessly with constrained access points and articulated instruments, which in turn accelerates demand for single-incision and multiport compatible assemblies.

From a procedural perspective, the pressure to reduce operative time and standardize outcomes is prompting clinicians to prefer solutions that reduce variability in suturing technique. This clinical imperative has fostered collaborations between device designers and surgical educators to embed knotless suturing into training curricula and simulation-based credentialing programs. Moreover, postoperative expectations from payors and patients-driven by quality metrics and shorter hospital stays-are steering device development toward technologies that demonstrably lower complication risks and enable consistent wound healing.

In parallel, supply chain resiliency and cost transparency are reshaping procurement behavior. Hospitals and specialty centers are emphasizing devices with clear lifecycle documentation, vendor-managed inventory options, and demonstrable sterilization and packaging efficiencies. Taken together, these shifts create opportunities for suppliers who can align material science, delivery ergonomics, and commercial models to the operational realities of modern surgical environments, while simultaneously addressing clinician preference and patient-centered outcomes.

Assessing the cascading effects of United States tariffs in 2025 on supply chains, component sourcing, regulatory alignment, and global procurement strategies

The introduction of United States tariffs in 2025 has introduced a new layer of complexity for manufacturers, distributors, and health systems that rely on transnational supply chains for critical device components and finished goods. Tariff-driven cost pressures have prompted firms to reassess sourcing strategies, prioritizing nearshore suppliers and diversified procurement channels to mitigate exposure to variable duties. Consequently, organizations are balancing the immediate cost implications of tariffs with longer-term capital investments to relocate critical manufacturing steps, qualify alternative materials, or redesign packaging and logistics to minimize taxable import thresholds.

Beyond cost, the tariff environment has ripple effects on production planning and inventory management. Manufacturers are increasingly adopting a dual approach: accelerating bilateral supplier qualification while implementing strategic buffer stocks for key components sensitive to tariff volatility. This strategy reduces production disruptions but also places a premium on working capital. Simultaneously, regulatory and quality teams must ensure that substitutions in suppliers or resins do not compromise device integrity or compliance with submission dossiers, which requires structured change control and supplemental testing.

International procurement and contracting teams have responded by renegotiating long-term agreements and exploring bonded logistics and free-trade zone opportunities to reduce customs exposure. For clinicians and hospital procurement leaders, the tariffs translate into a renewed emphasis on total cost of ownership that includes logistics duty, compliance risk, and the potential need for alternative product options. In sum, the tariff environment of 2025 is accelerating a strategic pivot toward supply-chain flexibility, localized manufacturing capabilities, and stronger cross-functional governance between sourcing, regulatory, and clinical teams.

Segment-focused intelligence revealing application, end-user, absorbability, delivery mode, and polymer structure dynamics that inform product development and positioning

Disaggregating the knotless tissue-closure landscape according to application, end-user, absorbability, mode of delivery, and polymer structure reveals differentiated innovation opportunities and commercialization pathways that vary by clinical need and care setting. By application, specialties such as cardiovascular, general surgery, gynecologic, ophthalmic, orthopedic, and plastic surgery each pose unique mechanical and handling requirements. Within cardiovascular procedures, valve repair and vascular anastomosis demand high tensile reliability and predictable long-term performance, whereas general surgery tasks like abdominal wall closure, gastrointestinal anastomosis, and hernia repair prioritize handling characteristics that support rapid intra-abdominal maneuvers. Gynecologic applications, including cesarean section, uterine suspension, and vaginal repair, require materials and delivery modalities that minimize tissue drag and reduce irritation in sensitive anatomic sites. Ophthalmic uses such as cataract surgery and corneal suturing call for ultra-fine profiles and minimal tissue reaction. Orthopedic applications covering arthroscopic closure, ligament repair, and tendon repair typically need robust knotless fixation and secure anchoring under cyclical loading, while plastic surgery applications for cosmetic and reconstructive surgery balance aesthetic outcomes with scar minimization.

Considering end users, adoption dynamics differ between ambulatory surgical centers, clinics, hospitals, and specialty centers. Ambulatory surgical centers, whether hospital affiliated or standalone, often prioritize devices that shorten turnover times and reduce inventory complexity. Clinics, including both hospital-affiliated clinics and independent clinics, place a premium on ease of use and disposability for staff with variable suturing experience. Hospitals, whether government-funded or private, emphasize procurement consistency, demonstrable clinical value, and integration into broader formularies. Specialty centers focused on ophthalmic or orthopedic care seek devices that address very specific procedural workflows and align with high-volume practice patterns.

Material selection and absorbability further stratify product fit. Absorbable options such as poliglecaprone, polydioxanone, polyglactin, and polyglycolic acid offer tailored degradation profiles for tissues that heal predictably, whereas nonabsorbable choices like nylon, polyester, and polypropylene provide long-term structural support where permanent reinforcement is required. Mode of delivery-laparoscopic, open, and robotic assisted-dictates device ergonomics and compatibility, with laparoscopic approaches differentiating between multiport and single incision systems and robotic-assisted workflows often requiring instruments compatible with specific platforms. Finally, polymer structure-braided or monofilament, each with coated or uncoated variants-affects handling, knotless anchoring characteristics, and tissue interaction. Understanding how these segmentation vectors intersect is critical for product designers aiming to match clinical performance with operational and economic realities across diverse care settings.

Regional dynamics and demand signals across the Americas, Europe Middle East and Africa, and Asia-Pacific that drive adoption, reimbursement, and distribution strategies

Regional dynamics play a pivotal role in shaping adoption curves, payer expectations, and distribution models for knotless tissue-closure devices across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, consolidated hospital systems and a focus on value-based procurement drive demand for devices that demonstrate consistent clinical outcomes and streamlined supply logistics. Early adopters in major urban centers often catalyze diffusion into community facilities, and reimbursement environments that reward efficiency can accelerate clinician uptake.

In Europe, Middle East & Africa, regulatory harmonization, variation in public procurement frameworks, and differing hospital funding approaches lead to a mosaic of adoption scenarios. Northern and Western European markets typically emphasize evidence generation and cost-effectiveness analyses, while markets in the Middle East and Africa show heterogeneity driven by infrastructure investments and regional centers of excellence. Across these geographies, distribution partnerships and local regulatory expertise can determine market entry speed and commercial traction.

The Asia-Pacific region presents opportunities driven by high procedural volumes, investments in minimally invasive surgery, and growing domestic manufacturing capabilities. However, fragmented reimbursement landscapes and procurement priorities that favor cost containment necessitate targeted value propositions that emphasize durability, ease of training, and supply chain assurances. Across all regions, successful commercialization depends on aligning clinical evidence strategies with regional regulatory expectations, leveraging local clinical champions, and designing distribution frameworks that reflect the operational nuances of each geography.

Competitive and collaboration patterns among established manufacturers, emerging innovators, contract manufacturers, and clinical partners informing go-to-market tactics

The competitive landscape for knotless tissue-closure devices is characterized by an interplay of established surgical manufacturers, specialized innovators, contract manufacturers, and collaborative clinical partnerships. Incumbent device manufacturers typically leverage broad commercial channels, existing surgeon relationships, and deep regulatory experience to accelerate adoption, whereas smaller technology-focused firms often differentiate through niche material science advancements or novel delivery mechanisms. Contract manufacturers and engineering service providers play an important role in enabling rapid prototyping, scale-up, and quality systems implementation for emerging firms that lack vertically integrated production.

Clinical partnerships are increasingly central to product validation and market acceptance. Strategic alliances between device developers and key opinion leaders in cardiovascular, general surgery, gynecology, ophthalmology, orthopedics, and plastic surgery enable iterative design improvements and create the clinical evidence base necessary for hospital formularies and purchasing committees. Concurrently, collaborative models that include shared-savings or gain-sharing agreements have emerged as alternatives to traditional purchasing, aligning manufacturer incentives with health system priorities around efficiency and outcomes.

Finally, competitive advantage is often determined by nonclinical capabilities such as supply chain robustness, regulatory agility, and the ability to provide comprehensive training and post-market surveillance. Companies that can demonstrate consistent quality, rapid response to field feedback, and structured clinician education are best positioned to capture traction in procedural areas where reproducibility and reliability are paramount.

Practical and actionable recommendations for industry leaders to accelerate adoption, de-risk commercialization, and optimize manufacturing and clinical evidence strategies

Industry leaders seeking to accelerate adoption and de-risk commercialization of knotless tissue-closure devices should pursue a coordinated set of actions spanning clinical data, manufacturing strategy, and commercial execution. First, prioritize the generation of comparative clinical evidence that focuses on reproducible endpoints meaningful to surgeons and procurement teams-such as closure integrity under physiologic loading, incidence of reintervention, and measures of procedural efficiency. Embedding prospective real-world evidence collection into early commercial rollouts can shorten the evidentiary timeline and support inclusion in procurement discussions.

Second, invest in supply chain resilience by qualifying multiple suppliers for critical polymers and components, exploring nearshore manufacturing alternatives, and implementing robust change-control processes to expedite regulatory notifications if materials or processes change. These steps reduce exposure to external shocks and support predictable fulfillment for high-volume centers. Third, design clinician training and onboarding programs tailored to each end-user environment, from ambulatory surgical centers to high-acuity hospitals and specialty clinics. Simulation-based training, proctoring for initial cases, and clear competency benchmarks will reduce variability in technique and support broader adoption.

Finally, align commercial models to reflect institutional priorities by offering flexible contracting, outcome-based pilots, and integrated inventory solutions. Engage early with reimbursement specialists and hospital value-analysis committees to articulate total cost implications, and consider strategic partnerships for clinical research, distribution, and service delivery to accelerate market penetration while preserving quality and compliance.

Transparent research methodology blending primary clinical interviews, device engineering assessments, and secondary literature synthesis to ensure analytical rigor

This analysis is founded on a mixed-methods research approach that blends primary qualitative interviews, device engineering assessments, and systematic secondary literature review to ensure analytical rigor and practical relevance. Primary research included structured interviews with clinicians across cardiovascular, general surgery, gynecology, ophthalmology, orthopedics, and plastic surgery, as well as dialogues with supply chain leaders, regulatory specialists, and device engineers to capture frontline operational constraints and technical priorities. These interviews informed hypothesis framing, highlighted critical use-case differentiation, and validated practical performance expectations for knotless closure technologies.

Engineering assessments focused on material selection, polymer architecture, and delivery-device mechanics, employing bench testing protocols to evaluate handling, tensile performance, and cyclic loading characteristics relevant to diverse anatomic sites. Where applicable, design verification data and peer-reviewed clinical outcomes were synthesized to contextualize device performance relative to procedural demands. Secondary research involved a comprehensive review of clinical guidelines, regulatory pathways, technical white papers, and publicly available safety communications to triangulate evidence and identify potential regulatory or reimbursement implications.

Data integrity was preserved through cross-validation across multiple sources and by documenting methodological assumptions and limitations. Where gaps existed, sensitivity analyses and expert elicitation provided qualitative triangulation. This structured approach supports actionable insights while maintaining transparency about evidence strengths and areas requiring further primary data collection during post-market surveillance or clinical studies.

Concluding synthesis of strategic implications and forward-looking considerations for stakeholders navigating the evolving knotless tissue-closure device landscape

The trajectory for knotless tissue-closure devices is shaped by technical refinements in polymer science, evolving surgical modalities, and shifting procurement expectations that prioritize demonstrable clinical value and supply-chain robustness. Stakeholders seeking to capitalize on these trends must approach product development and commercialization with a holistic lens that integrates clinical evidence, manufacturing flexibility, and targeted training pathways. Successful entrants will be those who align device performance to specific procedural needs-whether that be high-cycle orthopedic repairs, delicate ophthalmic closures, or high-throughput general surgery applications-while ensuring compatibility with existing instrumentation and clinical workflows.

Looking ahead, the most impactful innovations will likely arise at the intersection of material optimization, delivery ergonomics, and integrated clinician education. Coupled with adaptive commercial strategies that reflect regional regulatory and procurement nuances, these advances can facilitate broader adoption and improved patient outcomes. Ultimately, the landscape will favor organizations that commit to rigorous evidence generation, resilient supply chains, and sustained clinical engagement to translate device capabilities into real-world clinical benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Knotless Tissue-Closure Device Market, by Product Type

  • 8.1. Knotless Barbed Sutures
    • 8.1.1. Monofilament
    • 8.1.2. Braided
  • 8.2. Knotless Suture Anchors
    • 8.2.1. Soft Tissue Anchors
    • 8.2.2. Bone Anchors
  • 8.3. Knotless Closure Systems
    • 8.3.1. Skin Closure Systems
    • 8.3.2. Fascial Closure Systems
    • 8.3.3. Vascular Closure Systems
  • 8.4. Knotless Mesh Fixation Devices
  • 8.5. Adjunct Tensioning and Fixation Accessories

9. Knotless Tissue-Closure Device Market, by Absorbability

  • 9.1. Absorbable
    • 9.1.1. Poliglecaprone
    • 9.1.2. Polydioxanone
    • 9.1.3. Polyglactin
    • 9.1.4. Polyglycolic Acid
  • 9.2. Nonabsorbable
    • 9.2.1. Nylon
    • 9.2.2. Polyester
    • 9.2.3. Polypropylene

10. Knotless Tissue-Closure Device Market, by Mode Of Delivery

  • 10.1. Laparoscopic
    • 10.1.1. Multiport
    • 10.1.2. Single Incision
  • 10.2. Open
  • 10.3. Robotic Assisted

11. Knotless Tissue-Closure Device Market, by Polymer Structure

  • 11.1. Braided
    • 11.1.1. Coated
    • 11.1.2. Uncoated
  • 11.2. Monofilament
    • 11.2.1. Coated
    • 11.2.2. Uncoated

12. Knotless Tissue-Closure Device Market, by Application

  • 12.1. Cardiovascular
    • 12.1.1. Valve Repair
    • 12.1.2. Vascular Anastomosis
  • 12.2. General Surgery
    • 12.2.1. Abdominal Wall Closure
    • 12.2.2. Gastrointestinal Anastomosis
    • 12.2.3. Hernia Repair
  • 12.3. Gynecologic
    • 12.3.1. Cesarean Section
    • 12.3.2. Uterine Suspension
    • 12.3.3. Vaginal Repair
  • 12.4. Ophthalmic
    • 12.4.1. Cataract Surgery
    • 12.4.2. Corneal Suturing
  • 12.5. Orthopedic
    • 12.5.1. Arthroscopic Closure
    • 12.5.2. Ligament Repair
    • 12.5.3. Tendon Repair
  • 12.6. Plastic Surgery
    • 12.6.1. Cosmetic Surgery
    • 12.6.2. Reconstructive Surgery

13. Knotless Tissue-Closure Device Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital Affiliated
    • 13.1.2. Standalone
  • 13.2. Clinics
    • 13.2.1. Hospital Affiliated Clinics
    • 13.2.2. Independent Clinics
  • 13.3. Hospitals
    • 13.3.1. Government
    • 13.3.2. Private
  • 13.4. Specialty Centers
    • 13.4.1. Ophthalmic Specialty Centers
    • 13.4.2. Orthopedic Specialty Centers

14. Knotless Tissue-Closure Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Knotless Tissue-Closure Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Knotless Tissue-Closure Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Knotless Tissue-Closure Device Market

18. China Knotless Tissue-Closure Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Angelantoni Life Science S.r.l.
  • 19.7. Angiotech Pharmaceuticals, Inc.
  • 19.8. Arctiko A/S
  • 19.9. Aucma Co., Ltd.
  • 19.10. B. Braun Melsungen AG
  • 19.11. Baxter International Inc.
  • 19.12. Blue Star Limited
  • 19.13. ConMed Corporation
  • 19.14. Dometic Group AB
  • 19.15. Evermed S.R.L.
  • 19.16. Felix Storch, Inc.
  • 19.17. Fiocchetti S.r.l.
  • 19.18. Godrej & Boyce Manufacturing Co. Ltd.
  • 19.19. Johnson & Johnson
  • 19.20. Labcold Ltd.
  • 19.21. LEC Medical
  • 19.22. Medtronic plc
  • 19.23. Migali Scientific
  • 19.24. Smith & Nephew plc
  • 19.25. So-Low Environmental Equipment Co., Inc.
  • 19.26. Standex International Corporation
  • 19.27. Stryker Corporation
  • 19.28. Teleflex Incorporated
  • 19.29. Vestfrost
  • 19.30. Zhongke Meiling Cryogenics Company Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SOFT TISSUE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SOFT TISSUE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SOFT TISSUE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BONE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BONE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BONE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SKIN CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SKIN CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SKIN CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY FASCIAL CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY FASCIAL CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY FASCIAL CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS MESH FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS MESH FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS MESH FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ADJUNCT TENSIONING AND FIXATION ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ADJUNCT TENSIONING AND FIXATION ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ADJUNCT TENSIONING AND FIXATION ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLACTIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLACTIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLACTIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MULTIPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MULTIPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MULTIPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SINGLE INCISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SINGLE INCISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SINGLE INCISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR ANASTOMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR ANASTOMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR ANASTOMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL WALL CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL WALL CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL WALL CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GASTROINTESTINAL ANASTOMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GASTROINTESTINAL ANASTOMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GASTROINTESTINAL ANASTOMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CESAREAN SECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CESAREAN SECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UTERINE SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UTERINE SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UTERINE SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VAGINAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VAGINAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VAGINAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CORNEAL SUTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CORNEAL SUTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CORNEAL SUTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPIC CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPIC CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPIC CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LIGAMENT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LIGAMENT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LIGAMENT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY TENDON REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY TENDON REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY TENDON REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 240. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 241. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 242. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 245. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 264. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 266. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 270. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-203